AI assistant
AGENUS INC — Director's Dealing 2016
May 10, 2016
34023_dirs_2016-05-10_a91d24a4-8f37-47aa-a2e3-6ecdf277e676.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2016-05-05
Reporting Person: ARMEN GARO H (Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-05 | Common Stock | P | 50000 | $3.0792 | Acquired | 1346026 | Direct |
| 2016-05-09 | Common Stock | P | 50000 | $3.2787 | Acquired | 1396026 | Direct |
Footnotes
F1: This Form 4 reports the purchase, by Dr. Armen, of 100,000 shares of Agenus Inc. common stock. Of the 100,000 shares purchased by Dr. Armen and reported herein, 19,576 shares were matchable under Section 16(b) of the Securities Exchange Act of 1934 with Dr. Armen's sale of an equivalent number of shares of Agenus common stock at a weighted average price of $4.5715 per share on December 29, 2015. Dr. Armen has paid to Agenus, as of May 9, 2016, $27,714.24, representing the full amount of the profit realized in connection with the short-swing transaction.